Loading...
•
Jun 30, 2020
Applied Therapeutics Q2 2020 Earnings Report
Reported financial results for the second quarter of 2020.
Key Takeaways
Applied Therapeutics reported its financial results for the second quarter ended June 30, 2020, while continuing to advance its late-stage programs towards regulatory submission and commercial launch.
Advanced late-stage programs towards regulatory submission.
Focused on bringing drugs to patients in urgent need of treatment.
Pivotal Phase 1/2 clinical trial in Galactosemia read out positive top-line biomarker data.
Phase 3 registrational study in DbCM was initiated in September 2019.
Applied Therapeutics
Applied Therapeutics
Forward Guidance
The company remains focused on bringing drugs to patients in urgent need of treatment across multiple diseases, which they believe will ultimately drive shareholder value.